NASDAQ:ITOS

iTeos Therapeutics Earnings Date, Estimates & Call Transcripts (2022)

$20.60

-0.27 (-1.29%)

(As of 07/5/2022 03:32 PM ET)

Add

Compare

Today's Range: $20.43
▼
$21.21
50-Day Range: $16.57
▼
$28.14
52-Week Range: $16.21
▼
$52.43

Volume: 10,923 shs
Average Volume: 498,275 shs
Market Capitalization: $732.12 million

P/E Ratio: 2.64
Dividend Yield: N/A
Price Target: $47.33

Upcoming Earnings Date: Aug. 11Estimated
Actual EPS (May. 12): $1.82 Beat By $1.02
Consensus EPS (May. 12): $0.80
Last Year's Q2 EPS (5/13/2021): -$0.39

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

ITOS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ITOS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

iTeos Therapeutics Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2022	3	$0.57	$0.96	$0.80
Q2 2022	3	$0.50	$0.94	$0.76
Q3 2022	3	$0.47	$2.77	$1.34
Q4 2022	3	$0.38	$0.76	$0.62
FY 2022	12	$1.92	$5.43	$3.52
Q1 2023	1	$0.39	$0.39	$0.39
Q2 2023	1	$0.26	$0.26	$0.26
Q3 2023	1	$0.16	$0.16	$0.16
Q4 2023	1	($0.90)	($0.90)	($0.90)
FY 2023	4	($0.09)	($0.09)	($0.09)

ITOS Earnings Date and Information

iTeos Therapeutics last posted its quarterly earnings results on May 12th, 2022. The reported $1.82 EPS for the quarter, topping analysts' consensus estimates of $0.80 by $1.02. The firm earned $152.52 million during the quarter, compared to analysts' expectations of $63.30 million. iTeos Therapeutics has generated $7.81 earnings per share over the last year ($7.81 diluted earnings per share) and currently has a price-to-earnings ratio of 2.6. Earnings for iTeos Therapeutics are expected to decrease in the coming year, from $4.38 to ($2.85) per share. iTeos Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off prior year's report dates.

iTeos Therapeutics Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/11/2022 (Estimated)
5/12/2022	Q1 2022	$0.80	$1.82	+$1.02	$1.82	$63.30 million	$152.52 million
3/23/2022	Q4 2021	$1.29	$4.88	+$3.59	$4.88	$85.45 million	$240.50 million
11/10/2021	9/30/2021	$4.95	$1.86	($3.09)	$1.86	$329.75 million	$104.27 million
8/12/2021	6/30/2021	($0.41)	($0.75)	($0.34)	($0.75)
5/13/2021	3/31/2021	($0.48)	($0.39)	+$0.09	($0.39)
3/24/2021	Q4 2020		($0.43)	($0.43)	($0.43)
11/12/2020	9/30/2020	($0.37)	($0.48)	($0.11)	($0.48)

iTeos Therapeutics Earnings - Frequently Asked Questions

When is iTeos Therapeutics's earnings date?: iTeos Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off last year's report dates. Learn more on ITOS's earnings history.
Did iTeos Therapeutics beat their earnings estimates last quarter?: In the previous quarter, iTeos Therapeutics (NASDAQ:ITOS) reported $1.82 earnings per share (EPS) to beat the analysts' consensus estimate of $0.80 by $1.02. Learn more on analysts' earnings estimate vs. ITOS's actual earnings.
How can I listen to iTeos Therapeutics's earnings conference call?: The conference call for iTeos Therapeutics's latest earnings report can be listened to online. Listen to Conference Call
How can I read iTeos Therapeutics's conference call transcript?: The conference call transcript for iTeos Therapeutics's latest earnings report can be read online. Read Transcript

How much revenue does iTeos Therapeutics generate each year?: iTeos Therapeutics (NASDAQ:ITOS) has a recorded annual revenue of $344.77 million.
How much profit does iTeos Therapeutics generate each year?: iTeos Therapeutics (NASDAQ:ITOS) has a recorded net income of $214.52 million. ITOS has generated $7.81 earnings per share over the last four quarters.
What is iTeos Therapeutics's price-to-earnings ratio?: iTeos Therapeutics (NASDAQ:ITOS) has a trailing price-to-earnings ratio of 2.64 and a forward price-to-earnings ratio of 4.70.
What is iTeos Therapeutics's EPS forecast for next year?: iTeos Therapeutics's earnings are expected to decrease from $4.38 per share to ($2.85) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:

Earnings By Country:

Latest Articles:

Upcoming Earnings:

PepsiCo (7/12/2022)
América Móvil (7/12/2022)
Infosys (7/13/2022)
Morgan Stanley (7/14/2022)
JPMorgan Chase & Co. (7/14/2022)
Wells Fargo & Company (7/15/2022)
U.S. Bancorp (7/15/2022)
Citigroup (7/15/2022)
HDFC Bank (7/15/2022)
Charles Schwab (7/15/2022)

This page (NASDAQ:ITOS) was last updated on 7/5/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources